5-pregnene-3,20-diol has been researched along with Direct Hyperbilirubinemia, Neonatal in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Maruo, Y; Matsui, K; Mimura, Y; Ota, Y; Sato, H; Takeuchi, Y | 1 |
1 other study(ies) available for 5-pregnene-3,20-diol and Direct Hyperbilirubinemia, Neonatal
Article | Year |
---|---|
Inhibitory effect of 5β-pregnane-3α,20β-diol on transcriptional activity and enzyme activity of human bilirubin UDP-glucuronosyltransferase.
Topics: Cell Line; DNA Primers; DNA, Complementary; Gene Expression Regulation, Enzymologic; Genetic Vectors; Glucuronosyltransferase; Humans; Hyperbilirubinemia, Neonatal; In Vitro Techniques; Mutation, Missense; Pregnenolone; Promoter Regions, Genetic; Regression Analysis; Transcription Factors; Transfection | 2011 |